Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
about
Bendamustine salvage therapy for T cell neoplasms.Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaTreatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenHematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.Successful treatment of small cell variant anaplastic large cell lymphoma with allogeneic peripheral blood stem cell transplantation, and review of the literature.Romidepsin for peripheral T-cell lymphoma.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.From empiric to mechanism-based therapy for peripheral T cell lymphoma.Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Investigational drugs for T-cell lymphoma.How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Modelling lymphoma therapy and outcome.Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha/beta (αβ) T-cell lymphoma.ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma.Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology.Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party.Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation.Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
P2860
Q33407099-78A8ADCD-D088-4F77-BAE4-9BAC562D48C7Q33608520-990C4E69-B38A-4C4A-9365-707CC6CAE404Q34766846-1714F64C-9907-4F35-9F90-F8DC53A05495Q35533531-A17D826C-969A-4CA0-98DA-B0E1E16C3BEFQ35703714-DC8AFF87-8827-4825-9C79-5BE2A9B066FDQ36055223-B4A4CED3-9D4F-4202-B585-30C97EBCBCB9Q37122302-EB6AB86F-49AC-4068-8C20-DA011D10760AQ38069537-4A3AB47D-4B3A-420E-9EE5-3138AE365898Q38132813-DCA90738-83FB-4883-83A5-4FD52C9CD971Q38132821-23D55E3E-A2F5-41DD-A508-8784CA2180A3Q38186617-4F74999A-8602-4F79-81C5-0DCE9BDA6862Q38252378-B3AE064C-3FB1-4B79-AE6F-E49CF2E8BEAAQ38387292-E7CD8D16-CE06-4245-A69F-EE3AE16D9B3DQ38635909-FBBFD9A9-DE48-4500-88FC-583A8792E26EQ38782072-23E93879-0C12-4859-9E63-4574CDBAE350Q38860997-88DC13DD-F283-4190-B5F1-1197ADA4AC4BQ40421573-0FB27937-B952-4F22-9ECA-94E67701C3CFQ41106212-30E262E2-3E9B-4545-89CD-F998AF86F6ABQ41957184-5FB2C147-E702-4E14-8704-F48B15FB5A94Q43029183-A5A1486A-F348-4B57-91A8-CBC5D67E9FF0Q45124918-A358A478-6643-4FC6-AFC3-22F9A3723A2AQ46159472-DDD4BC77-1081-4CDD-B41E-BCE16FE32327Q52960823-57B19882-7D28-46AB-B18C-0B7F6604D219Q53060890-DF82F0C3-DA62-4A14-936F-F28A679004B7Q53769050-5EAD0CCE-C576-43BD-AA6D-B075B0A9B928Q58763961-9358FD73-3DD3-4B7F-BC39-A4242A7A934A
P2860
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@en
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@nl
type
label
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@en
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@nl
prefLabel
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@en
Allogeneic transplantation fol ...... graft-versus-lymphoma effect.
@nl
P2093
P2860
P50
P356
P1433
P1476
Allogeneic transplantation fol ...... a graft-versus-lymphoma effect
@en
P2093
A Rambaldi
E Pogliani
F Benedetti
F Patriarca
I Cavattoni
P2860
P2888
P304
P356
10.1038/LEU.2011.240
P577
2011-09-09T00:00:00Z